21hon MSN
The rise of ‘agonorexia’: People are developing brand new eating disorders on GLP-1 agonist drugs
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...
Is Obesity Genetic or Environmental? Get All the Details This article was reviewed by Lynn Marie Morski, MD, JD. Key ...
Research suggests there is not clear consensus about preferred terms to describe body size. Terms to describe body size in medical settings are often viewed as offensive to patients. Terms used to ...
The desire for smaller portions and fewer junk foods is affecting what the food industry is selling us.
Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...
Researchers predict the obesity rate among U.S. adults will rise to 47% of the population by 2035. Experts say this trend can ...
The post Oprah's Biggest Lessons About the Biology of Obesity appeared first on Katie Couric Media.
As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...
A renowned physician-scientist says treatment is not one-size-fits-all.
While GLP-1 drugs can alter the chemistry of hunger in powerful ways, they don’t necessarily help with the emotional and psychological factors often found at the root of eating disorders. There is ...
Chronically high levels of insulin and inflammation are key features of obesity and metabolic syndrome, which mediate cancer ...
New Scientist on MSN
Our oral microbiome could hold the key to preventing obesity
A distinct set of microbes has been identified in people with obesity, which might help spot and treat the condition early – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results